Dr. Zeier’s research efforts concern neurological diseases caused by repeat expansion mutations including Fragile X syndrome and C90rf72-related Amyotrophic Lateral Sclerosis (ALS).Dr. Zeier’s cancer-related interests include both epigenetic mechanisms and therapeutic development.